The nanoconjugate obtained by coating TMZ- and O6-benzylguanine-loaded exosomes with peptide aptamer anti-angiopep-2 peptide and RNA aptamer anti-CD133 has significantly increased the survival rate in GBM-xenografted mice compared with free drugs [102]. This evidence concerns the gene PROM1 and glioblastoma.